The global retinal drugs market is experiencing unprecedented growth, driven by a confluence of factors including rising prevalence of age-related macular degeneration (AMD), diabetic retinopathy, and other ocular conditions, coupled with breakthroughs in therapeutic innovation. Retinal diseases, which affect the light-sensitive tissue at the back of the eye, are a leading cause of vision loss...